Abstract:Background: The multi-drug resistance is an inherent weakness in the chemotherapeutics of non-small cell lung cancer occurring frequently all over the world. Clinically, ginseng and Chinese medicinal prescriptions including ginseng usually used as anti-tumor adjuncts due to its characteristic of qi-invigorating, which could improve the curative effect of chemotherapy drugs and reduce their toxic side effects. Triterpenoid saponins are the crucial active ingredients in Panax ginseng, and Ginsenoside Rb1 is of the highest quantities. However, the research on the tumor drug-resistance reversal effect and mechanism of ginsenoside Rb1 is still not clear. Purpose: This study aimed to systematically estimate the reversal activity of Ginsenoside Rb1 on cisplatin-insensitivity of A549/DDP cells and to reveal its prospective molecular mechanism. Methods: MTT assay were conducted to evaluate the reversal activity on cisplatin-insensitivity of A549/DDP cells of Ginsenoside Rb1in vitro, and the behavior was also studied by establishing a subcutaneous transplanted tumor model of A549/DDP in BALB/c-nu mice. In addition, P-gp ATPase activity assay, cisplatin accumulation assay, Annexin V-FITC apoptosis assay, real-time qPCR analysis and western blotting analysis were used to clarify the potential mechanism. Results: Ginsenoside Rb1 could effectively reverse the cisplatin-resistance of A549/DDP in vitro and vivo. And after the co-treatment of Ginsenoside Rb1 plus cisplatin, the accumulation of cisplatin increased in A549/DDP cells, which was accompanied with the down-regulation of the mRNA and protein expression levels of ABCB1, SHH, PTCH1 and GLI2. Besides, the apoptosis-inducing ability of cisplatin improved by the relative regulation on the protein expression level of Bax and Bcl-2. Far more importantly, the changes of CYP3A4 mRNA and protein levels were not significant. Conclusion: Ginsenoside Rb1 could increase the concentration of intracellular cisplatin and improve the insensitivity for cisplatin on A549/DDP cells. Even better, there was perhaps no unpredictable CYP3A4-mediated pharmacokinetic interactions after the combination of Ginsenoside Rb1 plus cisplatin. Ginsenoside Rb1 was a probable reversal agent for the cisplatin-insensitivity of A549/DDP cells, with a bifunction of inhibiting the efflux of two drug pumps (P-gp and PTCH1) by targeting ABCB1 and Hedgehog (Hh) pathway. In general, this research laid the groundwork for the development of a new reversal agent for the cisplatin-insensitivity of NSCLC.

Ginsenoside Rh2 Enhances the Apoptotic Effect of Cisplatin on PC-3M Prostatic Cancer Cells

Resveratrol Synergizes with Cisplatin in Antineoplastic Effects Against AGS Gastric Cancer Cells by Inducing Endoplasmic Reticulum Stress‑mediated Apoptosis and G2/M Phase Arrest.

Effect of Ginsenoside Rh2 on Renal Apoptosis in Cisplatin-Induced Nephrotoxicity in Vivo.

Effect of Ginsenoside Rh2 Combined with Cisplatin on Apoptosis of Human Ovarian Cancer SKOV-3 Cells

Study of inhibitory effects of Ginsenoside Rh2 on cultured PC-3M cell

Apoptosis of PC-3M Cells Induced by Rh2 and Effects of Rh2 on Expression of GRIM-19

Effects of ginsenoside Rh2 on cisplatin‐induced nephrotoxicity in renal tubular epithelial cells by inhibiting endoplasmic reticulum stress

[Research on the Mechanism of Ginsenoside Rh2 Reversing the Resistance of Lung Adenocarcinoma Cells to Cisplatin].

[Ginsenoside Rg3 Regulates Cisplatin Resistance in Gastric Cancer by Wnt/β-catenin Signaling Pathway].

Ginsenoside Rh4 Ameliorates Cisplatin-Induced Intestinal Toxicity Via PGC-1[Formula: See Text]-Mediated Mitochondrial Autophagy and Apoptosis Pathways.

Mechanism of regulating the resistance of prostate cancer PC-3 cells to cisplatin through enhancing cell gap junctions by evodiamine

Combination of cyanidin-3-O-glucoside and cisplatin induces oxidative stress and apoptosis in HeLa cells by reducing activity of endogenous antioxidants, increasing bax/bcl-2 mRNA expression ratio, and downregulating Nrf2 expression

Therapeutic effects of ginsenoside Rh2 on multi-drug resistant leukemia cell line K562 /VCR

Ginsenoside Rb3 Alleviates the Toxic Effect of Cisplatin on the Kidney During Its Treatment to Oral Cancer Via TGF-β-Mediated Mitochondrial Apoptosis.

Ginsenoside Rh2 Inhibits Prostate Cancer Cell Growth Through Suppression of Microrna‐4295 That Activates CDKN1A

Ginsenoside Rh2 Induces Apoptosis and Paraptosis-Like Cell Death in Colorectal Cancer Cells Through Activation of P53.

Synergy of 5-Aza-2'-deoxycytidine and Cisplatin in Prostate Cancer Cell Lines

Combination with vorinostat enhances the antitumor activity of cisplatin in castration-resistant prostate cancer by inhibiting DNA damage repair pathway and detoxification of GSH

Effect of Quercetin Combined with Cisplatin on the Proliferation and Apoptosis of Cervical Cancer HeLa Cells

Ginsenoside Rb1 for overcoming cisplatin-insensitivity of A549/DDP cells in vitro and vivo through the dual-inhibition on two efflux pumps of ABCB1 and PTCH1

Ginsenoside Rh2 Pretreatment and Withdrawal Reactivated the Pentose Phosphate Pathway to Ameliorate Intracellular Redox Disturbance and Promoted Intratumoral Penetration of Adriamycin